Martina Kalt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Martina Kalt has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Kathrin Fenner
Eawag, Swiss Federal Institute of Aquatic Science and Technology
3 shared publications - Bernhard Spingler
Department of Chemistry, University of Zürich, Zürich, Switzerland
2 shared publications - Christoph M. Meier
Department of Chemistry University of Zürich Winterthurerstrasse 190 8057 Zürich Switzerland
2 shared publications Elia Ceppi
2 shared publications- Lubomír Rulíšek
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo Náměstí 2, Praha 6 160 00, Czech Republic
2 shared publications - Lukas Schneider
Department of Chemistry, University of Zurich, CH-8057 Zurich, Switzerland
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Elsevier in Water Research
- Vol. 309
Assessing field-scale effects of treated wastewater on riverine biofilms: Community composition, functional genes, and micropollutant biotransformation
- 29 October 2026
- Published by Elsevier in Water Research
- Vol. 309
Open AccessAssessing field-scale effects of treated wastewater on riverine biofilms: Community composition, functional genes, and micropollutant biotransformation
- Top Cited PapersOpen Access
- 3 January 2026
- Published by Elsevier in Water Research
- Vol. 292, 125283
Breaking it down: Unveiling the roles of chemical structure, concentrations and technology on micropollutant biotransformation in wastewater treatment plants
- 3 January 2026
- Published by Elsevier in Water Research
- Vol. 292, 125283
Top Cited PapersOpen AccessBreaking it down: Unveiling the roles of chemical structure, concentrations and technology on micropollutant biotransformation in wastewater treatment plants
- Open Access
- 25 February 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (9) , 4597-4607
Preserving the Biotransformation Potential of Activated Sludge in Time: Toward Reproducible Incubation Experiments for Persistence Assessment
Biotransformation assays conducted in activated sludge (AS) from wastewater treatment plants (WWTPs) offer various benefits, most notably the high microbial density and comparably high bioavailability of the chemicals, enabling short experimental times of 72 h. Moreover, rate constants determined in AS experiments have shown the potential to be used as predictors for half-lives in other environmental compartments, such as soil. Therefore, biotransformation experiments with AS could serve as a valuable basis for developing standardized, high-throughput persistence tests used for screening purposes, e.g., in a benign-by-design framework, if reproducibility of experimental outcomes can be ensured. Here, we tested protocols for the preservation of AS microbial communities using lyophilization or cryopreservation. Their preservation performance was evaluated for 36 representative micropollutants (MPs) in 72 h, lab-scale batch experiments, with fresh AS as a reference. Cryopreservation, using either DMSO or glycerol as a protective agent, preserved the biotransformation potential for most of the MPs (∼65%), showing significant deviations in biotransformation kinetics almost exclusively for amine-containing substances. Lyophilization, however, performed worse with over ∼89% of MPs exhibiting significantly decreased or enhanced biotransformation compared to fresh AS. We further demonstrate nonsignificant impacts of storage time and the possibility of using artificial instead of preserved native supernatant. Major shifts in community composition based on 16S rRNA gene sequencing results aligned with biotransformation outcomes. Overall, the results suggest that our optimized cryopreservation protocol holds promise to preserve the biotransformation potential of AS and, upon further refinement and testing, might effectively support long-term reproducibility in persistence assessment.
- 25 February 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (9) , 4597-4607
Open AccessPreserving the Biotransformation Potential of Activated Sludge in Time: Toward Reproducible Incubation Experiments for Persistence Assessment
Biotransformation assays conducted in activated sludge (AS) from wastewater treatment plants (WWTPs) offer various benefits, most notably the high microbial density and comparably high bioavailability of the chemicals, enabling short experimental times of 72 h. Moreover, rate constants determined in AS experiments have shown the potential to be used as predictors for half-lives in other environmental compartments, such as soil. Therefore, biotransformation experiments with AS could serve as a valuable basis for developing standardized, high-throughput persistence tests used for screening purposes, e.g., in a benign-by-design framework, if reproducibility of experimental outcomes can be ensured. Here, we tested protocols for the preservation of AS microbial communities using lyophilization or cryopreservation. Their preservation performance was evaluated for 36 representative micropollutants (MPs) in 72 h, lab-scale batch experiments, with fresh AS as a reference. Cryopreservation, using either DMSO or glycerol as a protective agent, preserved the biotransformation potential for most of the MPs (∼65%), showing significant deviations in biotransformation kinetics almost exclusively for amine-containing substances. Lyophilization, however, performed worse with over ∼89% of MPs exhibiting significantly decreased or enhanced biotransformation compared to fresh AS. We further demonstrate nonsignificant impacts of storage time and the possibility of using artificial instead of preserved native supernatant. Major shifts in community composition based on 16S rRNA gene sequencing results aligned with biotransformation outcomes. Overall, the results suggest that our optimized cryopreservation protocol holds promise to preserve the biotransformation potential of AS and, upon further refinement and testing, might effectively support long-term reproducibility in persistence assessment.
- 11 June 2021
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 60 (13) , 9416-9426
Potent PBS/Polysorbate-Soluble Transplatin-Derived Porphyrin-Based Photosensitizers for Photodynamic Therapy
In this study, we addressed an important drawback of our previously reported tetraplatinated (metallo)porphyrin-based photosensitizers (PSs) for photodynamic therapy (PDT), namely, the poor solubility in aqueous media. We aimed to create tetraplatinated porphyrin-based PSs that are soluble in aqueous media modified with polysorbate (Tween) and do not need to be pre-dissolved in organic solvents. A structural optimization of the previously reported PSs resulted in the synthesis of an extremely potent novel porphyrin-based PS. The novel PS displays effective phototoxicity upon light irradiation against multicellular tumor spheroids and has a phototoxic index (PI) of 6030 in HeLa cells. This PI value is, to the best of our knowledge, the highest value reported for any porphyrin so far.
- 11 June 2021
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 60 (13) , 9416-9426
Potent PBS/Polysorbate-Soluble Transplatin-Derived Porphyrin-Based Photosensitizers for Photodynamic Therapy
In this study, we addressed an important drawback of our previously reported tetraplatinated (metallo)porphyrin-based photosensitizers (PSs) for photodynamic therapy (PDT), namely, the poor solubility in aqueous media. We aimed to create tetraplatinated porphyrin-based PSs that are soluble in aqueous media modified with polysorbate (Tween) and do not need to be pre-dissolved in organic solvents. A structural optimization of the previously reported PSs resulted in the synthesis of an extremely potent novel porphyrin-based PS. The novel PS displays effective phototoxicity upon light irradiation against multicellular tumor spheroids and has a phototoxic index (PI) of 6030 in HeLa cells. This PI value is, to the best of our knowledge, the highest value reported for any porphyrin so far.
- 23 March 2021
- Published by Wiley in Angewandte Chemie
- Vol. 133 (22) , 12489-12493
Potent Cyclic Tetrapeptide for Lead Detoxification
Lead (Pb) is a ubiquitous poisonous metal, affecting the health of vast populations worldwide. Medications to treat Pb poisoning suffer from various limitations and are often toxic owing to insufficient metal selectivity. Here, we report a cyclic tetrapeptide that selectively binds Pb and eradicates its toxic effect on the cellular level, with superior potency than state‐of‐the‐art drugs. The Pb‐peptide complex is remarkably strong and was characterized experimentally and computationally. Accompanied by the lack of toxicity and enhanced stability of this peptide, these qualities indicate its merit as a potential remedy for Pb poisoning.
- 23 March 2021
- Published by Wiley in Angewandte Chemie
- Vol. 133 (22) , 12489-12493
Potent Cyclic Tetrapeptide for Lead Detoxification
Lead (Pb) is a ubiquitous poisonous metal, affecting the health of vast populations worldwide. Medications to treat Pb poisoning suffer from various limitations and are often toxic owing to insufficient metal selectivity. Here, we report a cyclic tetrapeptide that selectively binds Pb and eradicates its toxic effect on the cellular level, with superior potency than state‐of‐the‐art drugs. The Pb‐peptide complex is remarkably strong and was characterized experimentally and computationally. Accompanied by the lack of toxicity and enhanced stability of this peptide, these qualities indicate its merit as a potential remedy for Pb poisoning.
- 23 March 2021
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (22) , 12381-12385
Potent Cyclic Tetrapeptide for Lead Detoxification
Lead (Pb) is a ubiquitous poisonous metal, affecting the health of vast populations worldwide. Medications to treat Pb poisoning suffer from various limitations and are often toxic owing to insufficient metal selectivity. Here, we report a cyclic tetrapeptide that selectively binds Pb and eradicates its toxic effect on the cellular level, with superior potency than state‐of‐the‐art drugs. The Pb‐peptide complex is remarkably strong and was characterized experimentally and computationally. Accompanied by the lack of toxicity and enhanced stability of this peptide, these qualities indicate its merit as a potential remedy for Pb poisoning.
- 23 March 2021
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (22) , 12381-12385
Potent Cyclic Tetrapeptide for Lead Detoxification
Lead (Pb) is a ubiquitous poisonous metal, affecting the health of vast populations worldwide. Medications to treat Pb poisoning suffer from various limitations and are often toxic owing to insufficient metal selectivity. Here, we report a cyclic tetrapeptide that selectively binds Pb and eradicates its toxic effect on the cellular level, with superior potency than state‐of‐the‐art drugs. The Pb‐peptide complex is remarkably strong and was characterized experimentally and computationally. Accompanied by the lack of toxicity and enhanced stability of this peptide, these qualities indicate its merit as a potential remedy for Pb poisoning.
- 8 November 2020
- Published by Wiley in ChemMedChem
- Vol. 16 (4) , 694-701
Highly Phototoxic Transplatin‐Modified Distyryl‐BODIPY Photosensitizers for Photodynamic Therapy
We report the synthesis of the first transplatin‐BODIPY conjugates for application in photodynamic therapy (PDT). The distyryl BODIPYs containing two iodine atoms were designed to absorb in the red region, easily undergo intersystem crossing for efficient singlet oxygen generation, and additionally offer the possibility for coordination with mono‐activated transplatin. We were able to demonstrate that coordination of the BODIPYs with a mono‐activated transplatin increases the phototoxic index of the photosensitizers significantly, giving rise to highly phototoxic distyryl BODIPY derivatives, of which one was shown to have the highest ever reported phototoxic index against any cell line. Furthermore, the photophysical mechanism of singlet oxygen generation in distyryl BODIPYs undergoing intramolecular charge transfer was studied experimentally and using time‐dependent density functional theory.
- 8 November 2020
- Published by Wiley in ChemMedChem
- Vol. 16 (4) , 694-701
Highly Phototoxic Transplatin‐Modified Distyryl‐BODIPY Photosensitizers for Photodynamic Therapy
We report the synthesis of the first transplatin‐BODIPY conjugates for application in photodynamic therapy (PDT). The distyryl BODIPYs containing two iodine atoms were designed to absorb in the red region, easily undergo intersystem crossing for efficient singlet oxygen generation, and additionally offer the possibility for coordination with mono‐activated transplatin. We were able to demonstrate that coordination of the BODIPYs with a mono‐activated transplatin increases the phototoxic index of the photosensitizers significantly, giving rise to highly phototoxic distyryl BODIPY derivatives, of which one was shown to have the highest ever reported phototoxic index against any cell line. Furthermore, the photophysical mechanism of singlet oxygen generation in distyryl BODIPYs undergoing intramolecular charge transfer was studied experimentally and using time‐dependent density functional theory.